Key indicators: single-crystal X-ray study; T = 100 K; mean (C-C) = 0.003 Å; R factor = 0.047; wR factor = 0.123; data-to-parameter ratio = 14.4.
Related literature

Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). (Kadi et al., 2007; El-Emam et al., 2004) . In continuation of our interest in the chemical and pharmacological properties of adamantane derivatives, and as part of on-going structural studies of adamantane derivatives (Kadi et al., 2011; AlTamimi et al., 2010) , the title compound, (I), was prepared as a potential chemotherapeutic agent.
The molecule of (I), 
The title compound was prepared following our previously described method (Kadi et al., 2007) . A mixture of 4-nitrobenzoic acid hydrazide (1.81 g, 0.01 mol), 1-adamantane carboxylic acid (1.8 g, 0.01 mol) and phosphorus oxychloride (8 ml) was heated under reflux for 1 h. On cooling, crushed ice (50 g) was added and the mixture was stirred for 30 min.
The separated crude product was filtered, washed with water, then with saturated sodium hydrogen carbonate solution and finally with water, dried and crystallized from EtOH/CHCl 3 to yield 2.96 g (91%) of the title compound as colourless crystals. M.pt.: 511-513 K. The molecular structure of (I) showing the atom-labelling scheme and displacement ellipsoids at the 50% probability level. 
